The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $114.52

Today's change+1.53 +1.35%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $114.52

Today's change+1.53 +1.35%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp up (U.S.)$1.53

Edwards Lifesciences Corp closed up Friday by (U.S.)$1.53 or 1.35% to (U.S.)$114.52. Over the last five days, shares have gained 7.78% and are currently 2.50% off of the 52-week high. Shares have outperformed the S&P 500 by 45.88% during the last year.

Key company metrics

  • Open(U.S.) $113.00
  • Previous close(U.S.) $112.99
  • High(U.S.) $114.79
  • Low(U.S.) $112.70
  • Bid / Ask-- / --
  • YTD % change+45.00%
  • Volume1,385,289
  • Average volume (10-day)1,645,708
  • Average volume (1-month)1,682,244
  • Average volume (3-month)1,784,012
  • 52-week range(U.S.) $62.53 to (U.S.) $117.46
  • Beta0.53
  • Trailing P/E47.37×
  • P/E 1 year forward39.85×
  • Forward PEG2.25×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.42
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue759697671616
Total other revenue--------
Total revenue759697671616
Gross profit557517495469
Total cost of revenue203180176147
Total operating expense590514504465
Selling / general / administrative229213222212
Research & development11310298101
Depreciation / amortization--------
Interest expense (income), net operating----54
Unusual expense (income)441232
Other operating expenses, total--510
Operating income169183167151
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax169183167151
Income after tax127143141118
Income tax, total42402633
Net income127143141118
Total adjustments to net income--------
Net income before extra. items127143141118
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items127143141118
Inc. avail. to common incl. extra. items127143141118
Diluted net income127143141118
Dilution adjustment--010
Diluted weighted average shares217218221220
Diluted EPS excluding extraordinary itemsvalue per share0.580.660.640.54
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.730.700.650.55